You are here

Vera Therapeutics’ stock could rise by 70%, according to Wall Street analysts

Vera Therapeutics’ stock could rise by 70%, according to Wall Street analysts

Submitted by admin on December 18, 2023 - 11:35am

Source:

Motley Fool

News Tags:

Vera Therapeutics

IgA nephropathy

Headline:

Vera Therapeutics’ stock could rise by 70%, according to Wall Street analysts

snippet:

Vera Therapeutics is a clinical stage company that some analysts think could be worth $1 billion.
The company could have an approved product for the treatment of IgA nephropathy by 2026.
It believes it has the cash and credit necessary for it to fund its business for the next few years.